Biotech Investors & VC Firms in Russia
19 firms in this list, with a median first check of $50K. Generated from verified public data and updated continuously.
Skolkovo–VTB Startup Academy
MoscowSeed
15 people
Kama Flow
MoscowSeed–Late Stage
2 people
GenerationS
MoscowSeed–Growth
Skolkovo Foundation
MoscowPre-Seed–Growth
5 people
Skolkovo Startup Academy / accelerator
MoscowPre-Seed–Seed
5 people
Mendeleev.Restart
MoscowPre-Seed–Growth$20K – $100K
Industrial Development Fund (FRP)
Seed–Series A$62.5K – $25M
Mendeleev Venture Capital
MoscowPre-Seed–Seed
1 person
RUSNANO
MoscowSeed–Late Stage
Artgen Seed Fund
Pre-Seed–Seed
Unicorn Capital Partners
Foundation for Assistance to Small Innovative Enterprises (FASIE / Bortnik Fund)
Pre-Seed–Seed
MIPT Startup Studio
Pre-Seed–Seed
ROSBIOTECH Startup Studio
Pre-Seed–Seed
SechenovTech
Pre-Seed–Seed
UMNIK Accelerator
Pre-Seed
University Venture Fund — KAMA FLOW
Pre-Seed–Seed
University Venture Fund — Voskhod
Pre-Seed–Seed
Amadeus Capital Partners
LondonPre-Seed–Late Stage$50K – $12.7M
27 people
Frequently asked questions
- Who are the top biotech investors & vc firms in russia?
- Top biotech investors & vc firms in russia include Skolkovo–VTB Startup Academy, Kama Flow, GenerationS, Skolkovo Foundation, Skolkovo Startup Academy / accelerator, Mendeleev.Restart, Industrial Development Fund (FRP), Mendeleev Venture Capital — 19 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in russia?
- The median first check among the 19 biotech investors & vc firms in russia tracked here is $50K.
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.





